Stifel Raises Medivation Inc (MDVN) PT to $66 with Company In Play
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Sanofi Comments on Medivation's Rejection of Proposal
April 29, 2016 9:05 AM EDTSanofi Comments on Medivation's Rejection of Proposal
-Reiterates Commitment to Consummating Transaction-
Paris, France - April 29, 2016 - Sanofi  today commented on Medivation, Inc.'s (NASDAQ: MDVN) rejection of Sanofi's non-binding all-cash proposal to acquire Medivation for $52.50 per share:
Combining Sanofi and Medivation represents a compelling strategic and financial opportunity to drive immediate and certain value for Medivation's... More
Medivation's Board of Directors Unanimously Rejects Sanofi's Unsolicited Proposal
April 29, 2016 8:45 AM EDTSAN FRANCISCO, CAÂ -- (Marketwired) -- 04/29/16 -- Medivation, Inc. (NASDAQ: MDVN) today announced that its Board of Directors, after consultation with its financial and legal advisors, unanimously determined that the unsolicited proposal from Sanofi to acquire Medivation for $52.50 per share in cash substantially undervalues Medivation and is not in the best interests of the company and its stockholders.Â
"Over the past several years, we have established a world class oncology franchise and a unique, diversified and highly-promising late-stage development pipeline," said David Hung, M.D., Founder, President and Chief Executive Officer of... More
